PORCIANI, MARIA CRISTINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.755
EU - Europa 1.227
AS - Asia 201
AF - Africa 2
SA - Sud America 2
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 3.189
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.755
PL - Polonia 526
SE - Svezia 177
IE - Irlanda 168
HK - Hong Kong 102
IT - Italia 102
UA - Ucraina 95
DE - Germania 71
FI - Finlandia 39
CN - Cina 27
GB - Regno Unito 25
SG - Singapore 22
JO - Giordania 21
TR - Turchia 12
FR - Francia 9
VN - Vietnam 8
BE - Belgio 5
IN - India 4
RU - Federazione Russa 4
CH - Svizzera 3
JP - Giappone 3
AE - Emirati Arabi Uniti 1
AU - Australia 1
BR - Brasile 1
CL - Cile 1
ES - Italia 1
EU - Europa 1
KR - Corea 1
MU - Mauritius 1
NL - Olanda 1
PT - Portogallo 1
SC - Seychelles 1
Totale 3.189
Salva come PNG Salva come JPEG
Città #
Warsaw 526
Chandler 240
Fairfield 229
Jacksonville 176
Dublin 168
Ashburn 134
Seattle 115
Cambridge 110
Woodbridge 104
Wilmington 81
Houston 76
Hong Kong 62
Boardman 42
Princeton 39
Boston 24
Altamura 23
Ann Arbor 22
Lawrence 22
Medford 21
San Diego 21
Kent 18
Buffalo 17
Singapore 15
New York 13
Beijing 11
Shanghai 11
Izmir 10
Florence 9
Capaccio 8
Bologna 7
Frankfurt Am Main 7
Los Angeles 7
Brussels 5
Duncan 5
Laurel 5
Milan 5
Norwalk 5
Auburn Hills 4
Arezzo 3
Bern 3
London 3
Minamiuebaru 3
Phoenix 3
Pune 3
Verona 3
Andover 2
Falls Church 2
Hillsboro 2
Orenburg 2
Pisa 2
Rome 2
San Mateo 2
Segrate 2
Tappahannock 2
West Jordan 2
Acate 1
Acton 1
Anzio 1
Bagno a Ripoli 1
Barcelona 1
Berlin 1
Bitritto 1
Brisbane 1
Council Bluffs 1
Dubai 1
Kilburn 1
Redwood City 1
Salerno 1
Seoul 1
Southend 1
São Paulo 1
Thrissur 1
Totale 2.455
Salva come PNG Salva come JPEG
Nome #
Evidence for oxidative stress in plasma of patients with Marfan syndrome 227
Vascular and connective tissue features in 5 italian patients with homocystinuria 211
High prevalence in ACE DD and genotype in patients with atrial fibrillation 205
May TGFBR1 act also as low penetrance ellele in marfan syndrome? 171
FBN1 mutation screening of patients with Marfan syndrome and related disorders: detection of 46 novel FBN1 mutations. 100
Application of the Seattle Heart Failure Model in patients on cardiac resynchronization therapy. 100
Association of Marfan syndrome and bicuspid aortic valve: Frequency and outcome 99
A single heterozygous nucleotide substitution displays two different altered mechanisms in the FBN1 gene of five Italian Marfan patients 94
AGT and ACE genes influence classic mitral valve prolapse predisposition in Marfan patients 93
Electrophysiologic procedures and activation of the hemostatic system 85
Diastolic subclinical primary alterations in Marfan syndrome and Marfan related disorders 84
ATRIAL FIBRILLATION AND CARDIAC RESYNCHRONIZATION THERAPY: THE MASCOT STUDY. 81
A real-time three-dimensional echocardiographic validation of an intracardiac electrogram-based method for optimizing cardiac resynchronization therapy. 81
Dual-site left ventricular cardiac resynchronization therapy. 77
Cardiac memory in humans: vectocardiographic quantification in cardiac resynchronization therapy. 76
Influence of age, lead axis, frequency of arrhythmic episodes, and atrial dimensions on P wave triggered SAECG in patients with lone paroxysmal atrial fibrillation 75
Acute hemodynamic effect of left ventricular endocardial pacing in cardiac resynchronization therapy: assessment by pressure-volume loops. 75
Relation of inflammatory status to major adverse cardiac events and reverse remodeling in patients undergoing cardiac resynchronization therapy 73
Cardiac resynchronization therapy: gender related differences in left ventricular reverse remodeling. 71
Multicenter experience with implantable defibrillators subject to recall. 71
Is ectopia lentis in some cases a mild phenotypic expression of Marfan syndrome? Need for a long-term follow-up. 70
Dural ectasia and FBN1 mutation screening of 40 patients with Marfan syndrome and related disorders: Role of dural ectasia for the diagnosis. 69
Phenotypic variability of cardiovascularmanifestations in Marfan Syndrome. Possible role of hyperhomocysteinemia andC677T MTHFR gene polymorphism. 65
Utility of a new left ventricular asynchrony index as a predictor of reverse remodelling after cardiac resynchronization therapy. 64
A major involvment of the cardiovascular system in patients affected by Marfan syndrome: novel mutations in fibrillin 1 gene. 62
Circadian Pattern of the QT Dispersion Using 3 Orthogonal Leads of an Holter ECG in Patients with Heart Failure. 62
Bioavailability of digoxin-hydroquinone complex 61
Atrioventricular interval optimazation in the right atrial appendage and interatrial septum pacing: a comparison between echo and peak endocardial acceleration measurements 54
Prognostic value of Doppler-derived mitral deceleration time on left ventricular reverse remodelling after undersized mitral annuloplasty 53
Marfan's syndrome. Clinical and molecular characterization of 51 italian patients 50
New therapeutic strategies in heart failure. Which patients need defibrillation backup? 46
Persistent subendocardial ischemia after hyperventilation 45
Wavelenght index at three atrial sites in patients with peroxysmal atrial fibrillation 44
Myocardial perfusion imaging using gated SPECT in heart failure patients undergoing cardiac resynchronization therapy. 44
Thoracic aortic aneurysm. New evidence for fibrillin-1 involvement 42
Interatrial septum pacing: a new approach to prevent recurrent atrial fibrillation 40
Prevention of short term reversible chronic atrial fibrillation by permanent pacing at the triangle of Koch 38
Paroxysmal atrial fibrillation: epidemiology and clinical relevance 36
Prevalence of cardiovascular manifestations in Marfan syndrome 34
Temporal Variation in Optimal Atrioventricular and Interventricular Delay During Cardiac Resynchronization Therapy 19
Resynchronization of mitral valve annular segments reduces functional mitral regurgitation in cardiac resynchronization therapy 18
Has mechanical dyssynchrony still a role in predicting cardiac resynchronization therapy response 18
Effects of cardiac resynchronization therapy on the mechanisms underlying functional mitral regurgitation in congestive heart failure 16
Rotational mechanics of the left ventricle in AL amyloidosis 14
Totale 3.213
Salva come PNG Salva come JPEG
Categoria #
all - tutte 9.216
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.216
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020641 56 66 16 63 66 78 58 88 54 31 58 7
2020/2021439 40 31 39 48 10 57 15 46 31 59 16 47
2021/2022238 6 26 6 12 15 9 7 13 10 15 52 67
2022/2023789 66 116 28 89 58 149 113 55 73 3 24 15
2023/2024316 20 33 48 26 13 45 13 76 3 3 28 8
2024/202520 20 0 0 0 0 0 0 0 0 0 0 0
Totale 3.213